First Horizon Corporation’s LeMaitre Vascular LMAT Stock Holding History

First Horizon Corporation’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.5K	Sell	276 -146	-35%	-$15K	﹤0.01%	890
2026 Q1	$46.1K	Hold	422	–	–	﹤0.01%	643
2025 Q4	$34.2K	Sell	422 -28	-6%	-$2.41K	﹤0.01%	793
2025 Q3	$39.4K	Buy	+450	New	+$40.2K	﹤0.01%	666

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Horizon Corporation's LMAT Position: Q2 2026 in Review

First Horizon Corporation reduced its LeMaitre Vascular (LMAT) stake by 35% in Q2 2026, selling an estimated $15K and leaving 276 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

First Horizon Corporation first reported a position in LMAT in Q3 2025 and has held it in 4 quarters since. The position peaked at $46.1K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

First Horizon Corporation held 276 shares of LeMaitre Vascular worth $26.5K as of Q2 2026.
First Horizon Corporation sold 146 LeMaitre Vascular shares in Q2 2026, an estimated $15K.
LeMaitre Vascular made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #890 holding.
First Horizon Corporation first reported a position in LeMaitre Vascular in Q3 2025 and has held it in 4 quarters since.
First Horizon Corporation's LeMaitre Vascular position peaked at $46.1K in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.